Recently, several studies have determined that overexpressing Sirt3 through preconditioning or genetic technology was able to activate Parkin-dependent mitophagy, which eliminated superfluous and damaged mitochondria in cardiomyocytes during diabetes [82, 86]. This evidence concerns the gene SIRT3 and diabetes mellitus.